Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
0 members / 5 guests []
Incyte Corporation
Board
Links
(more...)
Y!
INCY / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
133
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply A
GN
jerrykrause
0
11/10/2022 12:21:19 PM
132
Incyte's Opzelura shows significant improvements in phase 3 vitiligo trial
GN
jerrykrause
0
10/22/2022 12:20:02 PM
131
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremo
GN
jerrykrause
0
10/4/2022 5:41:19 PM
130
Incyte Announces U.S. FDA Has Extended the Supplemental New Drug Application Review Period for Ruxolitinib Cream (Opzelura™) for the Treatment of Vitiligo
GN
jerrykrause
0
3/16/2022 5:41:32 PM
129
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America
GN
jerrykrause
0
9/24/2021 1:10:52 PM
128
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
GN
jerrykrause
0
8/4/2021 8:51:02 PM
127
Lowering Our Incyte FVE to $116 Despite Solid Q2 on Potential U.S. Drug Pricing and Tax Reform
GN
jerrykrause
0
8/4/2021 8:03:32 PM
126
Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma
GN
jerrykrause
1
5/12/2021 5:20:05 PM
125
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time
GN
jerrykrause
0
4/21/2020 10:19:26 AM
124
Eli Lilly and Incyte report atopic dermatitis data of baricitinib
GN
jerrykrause
0
1/30/2020 1:48:00 PM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2023 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...